Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
about
Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severitySecondary outcomes of a pilot randomized trial of azithromycin treatment for asthmaA comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondromaLow-dose, long-term macrolide therapy in asthma: An overviewPhenotypes, Risk Factors, and Mechanisms of Adult-Onset AsthmaChlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPasesSeroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease.Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art reviewGenome sequencing and our understanding of chlamydiaeA protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children.Association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex.Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brainMacrolide antibiotics and the airway: antibiotic or non-antibiotic effects?Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis.Native properdin binds to Chlamydia pneumoniae and promotes complement activationNo evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction.Chlamydophila pneumoniae infection in adult asthmatics patients.Mechanisms of Chlamydophila pneumoniae-mediated GM-CSF release in human bronchial epithelial cells.Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection.Differences in cell activation by Chlamydophila pneumoniae and Chlamydia trachomatis infection in human endothelial cells.Evidence of chronic Chlamydia pneumoniae infection in patients with Behçet's disease.Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies.Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.Paraoxonase-1 gene in patients with chronic obstructive pulmonary disease investigation Q192R and L55M polymorphisms.Use of serology and polymerase chain reaction to detect atypical respiratory pathogens during acute exacerbation of chronic obstructive pulmonary disease
P2860
Q21090921-04A42EBD-8D53-44D4-92F9-16CEEFAEBED0Q21563468-D5889D03-8366-498C-88A8-1EC58E017198Q24797013-50179A27-1507-49DF-8BBA-BBD69DEEBBF0Q24806416-5B473774-2AC4-4D66-913A-2FF6045409E9Q26779940-398948F0-835A-4442-9E37-5C2B13EF5963Q28251473-0B64169F-79AF-402A-9AD5-487959F05538Q33599500-E4758BF1-3E78-42BA-80B5-5D8058678CB4Q33706917-6B839911-FEF9-4661-944E-BA088FC0A85BQ33975684-30943F93-0DFC-4040-A238-3AA81DE7D8BEQ34036110-FDC846E0-AE95-4EBC-89AE-C6C5F44EAB1CQ34082096-61B82303-E213-4921-B017-0EE5C1C396ACQ34104428-76865604-683E-47A1-91F2-6AEEB9BD62FDQ36225330-DA533758-0E4F-44C9-9C13-2EAC79BB202DQ37315230-1A684113-6A25-4360-B7D4-FCE5833E6C9DQ37691452-4B68C003-7408-4563-BDBE-320801181111Q37840798-E9F08014-2DAD-46D6-A32B-86DD28D55992Q37851796-B695705E-A0D8-4DBD-B39F-26B7DA46099AQ37857319-33653BC3-4EBB-4554-AA6B-2EB26A564968Q37858091-1DC5B30C-0252-4199-8FD0-78E83F0BB6C9Q37863354-C628359C-FD99-464E-A288-6744A830D138Q37865312-62AFF195-660C-4599-BBB3-2EA07931D98DQ37866228-274FF6A2-091F-49CC-8CA5-F05CD7FCD6D2Q37866634-E5CC887D-8F9E-4D70-93CD-1DAD1842D74EQ37867383-DF26DEA4-D8BB-4A55-A2CC-68ED5C861E96Q37871661-593455F7-1CBA-4B53-AEC6-A6F36A05DC8DQ37874322-987363A9-C33C-4551-B8ED-A25F6E65D42EQ40507900-35FA545C-CF3B-4F65-B917-6E736028A297Q57210774-4B1A6C39-0488-4765-AE7B-1533BAB9C146
P2860
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
@ast
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
@en
type
label
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
@ast
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
@en
prefLabel
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
@ast
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
@en
P1476
Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
@en
P2093
P304
271-88, 291; quiz 291-2
P356
10.1016/S1081-1206(10)62666-X
P577
1999-10-01T00:00:00Z